img

Global Coronary Heart Disease Medication Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Coronary Heart Disease Medication Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Coronary heart disease medications fall into two main categories. The first category is drugs that relieve insomnia and induce symptoms; mainly include beta-blockers, nitrates and calcium channel blockers. The second category is drugs that prevent myocardial infarction and improve ischemia. Mainly include drugs for anti-myocardial infarction and treatment of ischemic heart disease. It mainly includes anti-myocardial infarction drugs, anticoagulant drugs, β-blockers, angiotensin-converting enzyme or angiotensin II receptor blockers (ACEI/ARB) and statins.
Coronary Heart Disease Medication report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Coronary Heart Disease Medication market is projected to reach US$ 1082.6 million in 2029, increasing from US$ 739.3 million in 2022, with the CAGR of 5.6% during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Coronary Heart Disease Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AstraZeneca
Pfizer
Novartis
Merck & Co
Bayer
Buchang Pharmaceutical
China Resources Pharmaceutical
Tasly Pharmaceutical
Yiling Pharmaceutical
China Shineway Pharmaceutical
Shanghai Pharmaceuticals
Green Valley
North China Pharmaceutical
PKU HealthCare
Zhejiang Ruibang Laboratories
Segment by Type
Nitrates
Thrombolytic Drugs
β - receptor Blockers
Calcium Channel Blockers
Renin Angiotensin System Inhibitors
Statins
Proprietary Chinese Medicines
Others

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Coronary Heart Disease Medication market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Coronary Heart Disease Medication, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Coronary Heart Disease Medication industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Coronary Heart Disease Medication in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Coronary Heart Disease Medication introduction, etc. Coronary Heart Disease Medication Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Coronary Heart Disease Medication market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Coronary Heart Disease Medication Market Overview
1.1 Coronary Heart Disease Medication Product Overview
1.2 Coronary Heart Disease Medication Market Segment by Type
1.2.1 Nitrates
1.2.2 Thrombolytic Drugs
1.2.3 β - receptor Blockers
1.2.4 Calcium Channel Blockers
1.2.5 Renin Angiotensin System Inhibitors
1.2.6 Statins
1.2.7 Proprietary Chinese Medicines
1.2.8 Others
1.3 Global Coronary Heart Disease Medication Market Size by Type
1.3.1 Global Coronary Heart Disease Medication Market Size Overview by Type (2018-2029)
1.3.2 Global Coronary Heart Disease Medication Historic Market Size Review by Type (2018-2024)
1.3.3 Global Coronary Heart Disease Medication Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Coronary Heart Disease Medication Sales Breakdown by Type (2018-2024)
1.4.2 Europe Coronary Heart Disease Medication Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Coronary Heart Disease Medication Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Coronary Heart Disease Medication Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Coronary Heart Disease Medication Sales Breakdown by Type (2018-2024)
2 Global Coronary Heart Disease Medication Market Competition by Company
2.1 Global Top Players by Coronary Heart Disease Medication Sales (2018-2024)
2.2 Global Top Players by Coronary Heart Disease Medication Revenue (2018-2024)
2.3 Global Top Players by Coronary Heart Disease Medication Price (2018-2024)
2.4 Global Top Manufacturers Coronary Heart Disease Medication Manufacturing Base Distribution, Sales Area, Product Type
2.5 Coronary Heart Disease Medication Market Competitive Situation and Trends
2.5.1 Coronary Heart Disease Medication Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Coronary Heart Disease Medication Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Coronary Heart Disease Medication as of 2022)
2.7 Date of Key Manufacturers Enter into Coronary Heart Disease Medication Market
2.8 Key Manufacturers Coronary Heart Disease Medication Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Coronary Heart Disease Medication Status and Outlook by Region
3.1 Global Coronary Heart Disease Medication Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Coronary Heart Disease Medication Historic Market Size by Region
3.2.1 Global Coronary Heart Disease Medication Sales in Volume by Region (2018-2024)
3.2.2 Global Coronary Heart Disease Medication Sales in Value by Region (2018-2024)
3.2.3 Global Coronary Heart Disease Medication Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Coronary Heart Disease Medication Forecasted Market Size by Region
3.3.1 Global Coronary Heart Disease Medication Sales in Volume by Region (2024-2029)
3.3.2 Global Coronary Heart Disease Medication Sales in Value by Region (2024-2029)
3.3.3 Global Coronary Heart Disease Medication Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Coronary Heart Disease Medication by Application
4.1 Coronary Heart Disease Medication Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Coronary Heart Disease Medication Market Size by Application
4.2.1 Global Coronary Heart Disease Medication Market Size Overview by Application (2018-2029)
4.2.2 Global Coronary Heart Disease Medication Historic Market Size Review by Application (2018-2024)
4.2.3 Global Coronary Heart Disease Medication Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Coronary Heart Disease Medication Sales Breakdown by Application (2018-2024)
4.3.2 Europe Coronary Heart Disease Medication Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Coronary Heart Disease Medication Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Coronary Heart Disease Medication Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Coronary Heart Disease Medication Sales Breakdown by Application (2018-2024)
5 North America Coronary Heart Disease Medication by Country
5.1 North America Coronary Heart Disease Medication Historic Market Size by Country
5.1.1 North America Coronary Heart Disease Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Coronary Heart Disease Medication Sales in Volume by Country (2018-2024)
5.1.3 North America Coronary Heart Disease Medication Sales in Value by Country (2018-2024)
5.2 North America Coronary Heart Disease Medication Forecasted Market Size by Country
5.2.1 North America Coronary Heart Disease Medication Sales in Volume by Country (2024-2029)
5.2.2 North America Coronary Heart Disease Medication Sales in Value by Country (2024-2029)
6 Europe Coronary Heart Disease Medication by Country
6.1 Europe Coronary Heart Disease Medication Historic Market Size by Country
6.1.1 Europe Coronary Heart Disease Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Coronary Heart Disease Medication Sales in Volume by Country (2018-2024)
6.1.3 Europe Coronary Heart Disease Medication Sales in Value by Country (2018-2024)
6.2 Europe Coronary Heart Disease Medication Forecasted Market Size by Country
6.2.1 Europe Coronary Heart Disease Medication Sales in Volume by Country (2024-2029)
6.2.2 Europe Coronary Heart Disease Medication Sales in Value by Country (2024-2029)
7 Asia-Pacific Coronary Heart Disease Medication by Region
7.1 Asia-Pacific Coronary Heart Disease Medication Historic Market Size by Region
7.1.1 Asia-Pacific Coronary Heart Disease Medication Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Coronary Heart Disease Medication Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Coronary Heart Disease Medication Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Coronary Heart Disease Medication Forecasted Market Size by Region
7.2.1 Asia-Pacific Coronary Heart Disease Medication Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Coronary Heart Disease Medication Sales in Value by Region (2024-2029)
8 Latin America Coronary Heart Disease Medication by Country
8.1 Latin America Coronary Heart Disease Medication Historic Market Size by Country
8.1.1 Latin America Coronary Heart Disease Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Coronary Heart Disease Medication Sales in Volume by Country (2018-2024)
8.1.3 Latin America Coronary Heart Disease Medication Sales in Value by Country (2018-2024)
8.2 Latin America Coronary Heart Disease Medication Forecasted Market Size by Country
8.2.1 Latin America Coronary Heart Disease Medication Sales in Volume by Country (2024-2029)
8.2.2 Latin America Coronary Heart Disease Medication Sales in Value by Country (2024-2029)
9 Middle East and Africa Coronary Heart Disease Medication by Country
9.1 Middle East and Africa Coronary Heart Disease Medication Historic Market Size by Country
9.1.1 Middle East and Africa Coronary Heart Disease Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Coronary Heart Disease Medication Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Coronary Heart Disease Medication Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Coronary Heart Disease Medication Forecasted Market Size by Country
9.2.1 Middle East and Africa Coronary Heart Disease Medication Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Coronary Heart Disease Medication Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Coronary Heart Disease Medication Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AstraZeneca Coronary Heart Disease Medication Products Offered
10.1.5 AstraZeneca Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Coronary Heart Disease Medication Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Pfizer Coronary Heart Disease Medication Products Offered
10.2.5 Pfizer Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Coronary Heart Disease Medication Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novartis Coronary Heart Disease Medication Products Offered
10.3.5 Novartis Recent Development
10.4 Merck & Co
10.4.1 Merck & Co Company Information
10.4.2 Merck & Co Introduction and Business Overview
10.4.3 Merck & Co Coronary Heart Disease Medication Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck & Co Coronary Heart Disease Medication Products Offered
10.4.5 Merck & Co Recent Development
10.5 Bayer
10.5.1 Bayer Company Information
10.5.2 Bayer Introduction and Business Overview
10.5.3 Bayer Coronary Heart Disease Medication Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Bayer Coronary Heart Disease Medication Products Offered
10.5.5 Bayer Recent Development
10.6 Buchang Pharmaceutical
10.6.1 Buchang Pharmaceutical Company Information
10.6.2 Buchang Pharmaceutical Introduction and Business Overview
10.6.3 Buchang Pharmaceutical Coronary Heart Disease Medication Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Buchang Pharmaceutical Coronary Heart Disease Medication Products Offered
10.6.5 Buchang Pharmaceutical Recent Development
10.7 China Resources Pharmaceutical
10.7.1 China Resources Pharmaceutical Company Information
10.7.2 China Resources Pharmaceutical Introduction and Business Overview
10.7.3 China Resources Pharmaceutical Coronary Heart Disease Medication Sales, Revenue and Gross Margin (2018-2024)
10.7.4 China Resources Pharmaceutical Coronary Heart Disease Medication Products Offered
10.7.5 China Resources Pharmaceutical Recent Development
10.8 Tasly Pharmaceutical
10.8.1 Tasly Pharmaceutical Company Information
10.8.2 Tasly Pharmaceutical Introduction and Business Overview
10.8.3 Tasly Pharmaceutical Coronary Heart Disease Medication Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Tasly Pharmaceutical Coronary Heart Disease Medication Products Offered
10.8.5 Tasly Pharmaceutical Recent Development
10.9 Yiling Pharmaceutical
10.9.1 Yiling Pharmaceutical Company Information
10.9.2 Yiling Pharmaceutical Introduction and Business Overview
10.9.3 Yiling Pharmaceutical Coronary Heart Disease Medication Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Yiling Pharmaceutical Coronary Heart Disease Medication Products Offered
10.9.5 Yiling Pharmaceutical Recent Development
10.10 China Shineway Pharmaceutical
10.10.1 China Shineway Pharmaceutical Company Information
10.10.2 China Shineway Pharmaceutical Introduction and Business Overview
10.10.3 China Shineway Pharmaceutical Coronary Heart Disease Medication Sales, Revenue and Gross Margin (2018-2024)
10.10.4 China Shineway Pharmaceutical Coronary Heart Disease Medication Products Offered
10.10.5 China Shineway Pharmaceutical Recent Development
10.11 Shanghai Pharmaceuticals
10.11.1 Shanghai Pharmaceuticals Company Information
10.11.2 Shanghai Pharmaceuticals Introduction and Business Overview
10.11.3 Shanghai Pharmaceuticals Coronary Heart Disease Medication Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Shanghai Pharmaceuticals Coronary Heart Disease Medication Products Offered
10.11.5 Shanghai Pharmaceuticals Recent Development
10.12 Green Valley
10.12.1 Green Valley Company Information
10.12.2 Green Valley Introduction and Business Overview
10.12.3 Green Valley Coronary Heart Disease Medication Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Green Valley Coronary Heart Disease Medication Products Offered
10.12.5 Green Valley Recent Development
10.13 North China Pharmaceutical
10.13.1 North China Pharmaceutical Company Information
10.13.2 North China Pharmaceutical Introduction and Business Overview
10.13.3 North China Pharmaceutical Coronary Heart Disease Medication Sales, Revenue and Gross Margin (2018-2024)
10.13.4 North China Pharmaceutical Coronary Heart Disease Medication Products Offered
10.13.5 North China Pharmaceutical Recent Development
10.14 PKU HealthCare
10.14.1 PKU HealthCare Company Information
10.14.2 PKU HealthCare Introduction and Business Overview
10.14.3 PKU HealthCare Coronary Heart Disease Medication Sales, Revenue and Gross Margin (2018-2024)
10.14.4 PKU HealthCare Coronary Heart Disease Medication Products Offered
10.14.5 PKU HealthCare Recent Development
10.15 Zhejiang Ruibang Laboratories
10.15.1 Zhejiang Ruibang Laboratories Company Information
10.15.2 Zhejiang Ruibang Laboratories Introduction and Business Overview
10.15.3 Zhejiang Ruibang Laboratories Coronary Heart Disease Medication Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Zhejiang Ruibang Laboratories Coronary Heart Disease Medication Products Offered
10.15.5 Zhejiang Ruibang Laboratories Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Coronary Heart Disease Medication Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Coronary Heart Disease Medication Industrial Chain Analysis
11.4 Coronary Heart Disease Medication Market Dynamics
11.4.1 Coronary Heart Disease Medication Industry Trends
11.4.2 Coronary Heart Disease Medication Market Drivers
11.4.3 Coronary Heart Disease Medication Market Challenges
11.4.4 Coronary Heart Disease Medication Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Coronary Heart Disease Medication Distributors
12.3 Coronary Heart Disease Medication Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Nitrates
Table 2. Major Company of Thrombolytic Drugs
Table 3. Major Company of β - receptor Blockers
Table 4. Major Company of Calcium Channel Blockers
Table 5. Major Company of Renin Angiotensin System Inhibitors
Table 6. Major Company of Statins
Table 7. Major Company of Proprietary Chinese Medicines
Table 8. Major Company of Others
Table 9. Global Coronary Heart Disease Medication Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Coronary Heart Disease Medication Sales by Type (2018-2024) & (K Units)
Table 11. Global Coronary Heart Disease Medication Sales Market Share in Volume by Type (2018-2024)
Table 12. Global Coronary Heart Disease Medication Sales by Type (2018-2024) & (US& Million)
Table 13. Global Coronary Heart Disease Medication Market Share in Value by Type (2018-2024)
Table 14. Global Coronary Heart Disease Medication Price by Type (2018-2024) & (US$/Unit)
Table 15. Global Coronary Heart Disease Medication Sales by Type (2024-2029) & (K Units)
Table 16. Global Coronary Heart Disease Medication Sales Market Share in Volume by Type (2024-2029)
Table 17. Global Coronary Heart Disease Medication Sales by Type (2024-2029) & (US$ Million)
Table 18. Global Coronary Heart Disease Medication Sales Market Share in Value by Type (2024-2029)
Table 19. Global Coronary Heart Disease Medication Price by Type (2024-2029) & (US$/Unit)
Table 20. North America Coronary Heart Disease Medication Sales by Type (2018-2024) & (K Units)
Table 21. North America Coronary Heart Disease Medication Sales by Type (2018-2024) & (US$ Million)
Table 22. Europe Coronary Heart Disease Medication Sales (K Units) by Type (2018-2024)
Table 23. Europe Coronary Heart Disease Medication Sales by Type (2018-2024) & (US$ Million)
Table 24. Asia-Pacific Coronary Heart Disease Medication Sales (K Units) by Type (2018-2024)
Table 25. Asia-Pacific Coronary Heart Disease Medication Sales by Type (2018-2024) & (US$ Million)
Table 26. Latin America Coronary Heart Disease Medication Sales (K Units) by Type (2018-2024)
Table 27. Latin America Coronary Heart Disease Medication Sales by Type (2018-2024) & (US$ Million)
Table 28. Middle East and Africa Coronary Heart Disease Medication Sales (K Units) by Type (2018-2024)
Table 29. Middle East and Africa Coronary Heart Disease Medication Sales by Type (2018-2024) & (US$ Million)
Table 30. Global Coronary Heart Disease Medication Sales by Company (2018-2024) & (K Units)
Table 31. Global Coronary Heart Disease Medication Sales Share by Company (2018-2024)
Table 32. Global Coronary Heart Disease Medication Revenue by Company (2018-2024) & (US$ Million)
Table 33. Global Coronary Heart Disease Medication Revenue Share by Company (2018-2024)
Table 34. Global Market Coronary Heart Disease Medication Price by Company (2018-2024) & (US$/Unit)
Table 35. Global Coronary Heart Disease Medication Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 36. Global Coronary Heart Disease Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 37. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Coronary Heart Disease Medication as of 2022)
Table 38. Date of Key Manufacturers Enter into Coronary Heart Disease Medication Market
Table 39. Key Manufacturers Coronary Heart Disease Medication Product Type
Table 40. Mergers & Acquisitions, Expansion Plans
Table 41. Global Coronary Heart Disease Medication Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Global Coronary Heart Disease Medication Sales by Region (2018-2024) & (K Units)
Table 43. Global Coronary Heart Disease Medication Sales Market Share in Volume by Region (2018-2024)
Table 44. Global Coronary Heart Disease Medication Sales by Region (2018-2024) & (US$ Million)
Table 45. Global Coronary Heart Disease Medication Sales Market Share in Value by Region (2018-2024)
Table 46. Global Coronary Heart Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 47. Global Coronary Heart Disease Medication Sales by Region (2024-2029) & (K Units)
Table 48. Global Coronary Heart Disease Medication Sales Market Share in Volume by Region (2024-2029)
Table 49. Global Coronary Heart Disease Medication Sales by Region (2024-2029) & (US$ Million)
Table 50. Global Coronary Heart Disease Medication Sales Market Share in Value by Region (2024-2029)
Table 51. Global Coronary Heart Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 52. Global Coronary Heart Disease Medication Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 53. Global Coronary Heart Disease Medication Sales by Application (2018-2024) & (K Units)
Table 54. Global Coronary Heart Disease Medication Sales Market Share in Volume by Application (2018-2024)
Table 55. Global Coronary Heart Disease Medication Sales by Application (2018-2024) & (US$ Million)
Table 56. Global Coronary Heart Disease Medication Sales Market Share in Value by Application (2018-2024)
Table 57. Global Coronary Heart Disease Medication Price by Application (2018-2024) & (US$/Unit)
Table 58. Global Coronary Heart Disease Medication Sales by Application (2024-2029) & (K Units)
Table 59. Global Coronary Heart Disease Medication Sales Market Share in Volume by Application (2024-2029)
Table 60. Global Coronary Heart Disease Medication Sales by Application (2024-2029) & (US$ Million)
Table 61. Global Coronary Heart Disease Medication Sales Market Share in Value by Application (2024-2029)
Table 62. Global Coronary Heart Disease Medication Price by Application (2024-2029) & (US$/Unit)
Table 63. North America Coronary Heart Disease Medication Sales by Application (2018-2024) (K Units)
Table 64. North America Coronary Heart Disease Medication Sales by Application (2018-2024) & (US$ Million)
Table 65. Europe Coronary Heart Disease Medication Sales by Application (2018-2024) (K Units)
Table 66. Europe Coronary Heart Disease Medication Sales by Application (2018-2024) & (US$ Million)
Table 67. Asia-Pacific Coronary Heart Disease Medication Sales by Application (2018-2024) (K Units)
Table 68. Asia-Pacific Coronary Heart Disease Medication Sales by Application (2018-2024) & (US$ Million)
Table 69. Latin America Coronary Heart Disease Medication Sales by Application (2018-2024) (K Units)
Table 70. Latin America Coronary Heart Disease Medication Sales by Application (2018-2024) & (US$ Million)
Table 71. Middle East and Africa Coronary Heart Disease Medication Sales by Application (2018-2024) (K Units)
Table 72. Middle East and Africa Coronary Heart Disease Medication Sales by Application (2018-2024) & (US$ Million)
Table 73. North America Coronary Heart Disease Medication Sales by Country (2018-2024) & (K Units)
Table 74. North America Coronary Heart Disease Medication Sales Market Share in Volume by Country (2018-2024)
Table 75. North America Coronary Heart Disease Medication Sales by Country (2018-2024) & (US$ Million)
Table 76. North America Coronary Heart Disease Medication Sales Market Share in Value by Country (2018-2024)
Table 77. North America Coronary Heart Disease Medication Sales by Country (2024-2029) & (K Units)
Table 78. North America Coronary Heart Disease Medication Sales Market Share in Volume by Country (2024-2029)
Table 79. North America Coronary Heart Disease Medication Sales by Country (2024-2029) & (US$ Million)
Table 80. North America Coronary Heart Disease Medication Sales Market Share in Value by Country (2024-2029)
Table 81. Europe Coronary Heart Disease Medication Sales by Country (2018-2024) & (K Units)
Table 82. Europe Coronary Heart Disease Medication Sales Market Share in Volume by Country (2018-2024)
Table 83. Europe Coronary Heart Disease Medication Sales by Country (2018-2024) & (US$ Million)
Table 84. Europe Coronary Heart Disease Medication Sales Market Share in Value by Country (2018-2024)
Table 85. Europe Coronary Heart Disease Medication Sales by Country (2024-2029) & (K Units)
Table 86. Europe Coronary Heart Disease Medication Sales Market Share in Volume by Country (2024-2029)
Table 87. Europe Coronary Heart Disease Medication Sales by Country (2024-2029) & (US$ Million)
Table 88. Europe Coronary Heart Disease Medication Sales Market Share in Value by Country (2024-2029)
Table 89. Asia-Pacific Coronary Heart Disease Medication Sales by Region (2018-2024) & (K Units)
Table 90. Asia-Pacific Coronary Heart Disease Medication Sales Market Share in Volume by Region (2018-2024)
Table 91. Asia-Pacific Coronary Heart Disease Medication Sales by Region (2018-2024) & (US$ Million)
Table 92. Asia-Pacific Coronary Heart Disease Medication Sales Market Share in Value by Region (2018-2024)
Table 93. Asia-Pacific Coronary Heart Disease Medication Sales by Region (2024-2029) & (K Units)
Table 94. Asia-Pacific Coronary Heart Disease Medication Sales Market Share in Volume by Region (2024-2029)
Table 95. Asia-Pacific Coronary Heart Disease Medication Sales by Region (2024-2029) & (US$ Million)
Table 96. Asia-Pacific Coronary Heart Disease Medication Sales Market Share in Value by Region (2024-2029)
Table 97. Latin America Coronary Heart Disease Medication Sales by Country (2018-2024) & (K Units)
Table 98. Latin America Coronary Heart Disease Medication Sales Market Share in Volume by Country (2018-2024)
Table 99. Latin America Coronary Heart Disease Medication Sales by Country (2018-2024) & (US$ Million)
Table 100. Latin America Coronary Heart Disease Medication Sales Market Share in Value by Country (2018-2024)
Table 101. Latin America Coronary Heart Disease Medication Sales by Country (2024-2029) & (K Units)
Table 102. Latin America Coronary Heart Disease Medication Sales Market Share in Volume by Country (2024-2029)
Table 103. Latin America Coronary Heart Disease Medication Sales by Country (2024-2029) & (US$ Million)
Table 104. Latin America Coronary Heart Disease Medication Sales Market Share in Value by Country (2024-2029)
Table 105. Middle East and Africa Coronary Heart Disease Medication Sales by Country (2018-2024) & (K Units)
Table 106. Middle East and Africa Coronary Heart Disease Medication Sales Market Share in Volume by Country (2018-2024)
Table 107. Middle East and Africa Coronary Heart Disease Medication Sales by Country (2018-2024) & (US$ Million)
Table 108. Middle East and Africa Coronary Heart Disease Medication Sales Market Share in Value by Country (2018-2024)
Table 109. Middle East and Africa Coronary Heart Disease Medication Sales by Country (2024-2029) & (K Units)
Table 110. Middle East and Africa Coronary Heart Disease Medication Sales Market Share in Volume by Country (2024-2029)
Table 111. Middle East and Africa Coronary Heart Disease Medication Sales by Country (2024-2029) & (US$ Million)
Table 112. Middle East and Africa Coronary Heart Disease Medication Sales Market Share in Value by Country (2024-2029)
Table 113. AstraZeneca Company Information
Table 114. AstraZeneca Introduction and Business Overview
Table 115. AstraZeneca Coronary Heart Disease Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. AstraZeneca Coronary Heart Disease Medication Product
Table 117. AstraZeneca Recent Development
Table 118. Pfizer Company Information
Table 119. Pfizer Introduction and Business Overview
Table 120. Pfizer Coronary Heart Disease Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Pfizer Coronary Heart Disease Medication Product
Table 122. Pfizer Recent Development
Table 123. Novartis Company Information
Table 124. Novartis Introduction and Business Overview
Table 125. Novartis Coronary Heart Disease Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Novartis Coronary Heart Disease Medication Product
Table 127. Novartis Recent Development
Table 128. Merck & Co Company Information
Table 129. Merck & Co Introduction and Business Overview
Table 130. Merck & Co Coronary Heart Disease Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Merck & Co Coronary Heart Disease Medication Product
Table 132. Merck & Co Recent Development
Table 133. Bayer Company Information
Table 134. Bayer Introduction and Business Overview
Table 135. Bayer Coronary Heart Disease Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Bayer Coronary Heart Disease Medication Product
Table 137. Bayer Recent Development
Table 138. Buchang Pharmaceutical Company Information
Table 139. Buchang Pharmaceutical Introduction and Business Overview
Table 140. Buchang Pharmaceutical Coronary Heart Disease Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Buchang Pharmaceutical Coronary Heart Disease Medication Product
Table 142. Buchang Pharmaceutical Recent Development
Table 143. China Resources Pharmaceutical Company Information
Table 144. China Resources Pharmaceutical Introduction and Business Overview
Table 145. China Resources Pharmaceutical Coronary Heart Disease Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. China Resources Pharmaceutical Coronary Heart Disease Medication Product
Table 147. China Resources Pharmaceutical Recent Development
Table 148. Tasly Pharmaceutical Company Information
Table 149. Tasly Pharmaceutical Introduction and Business Overview
Table 150. Tasly Pharmaceutical Coronary Heart Disease Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Tasly Pharmaceutical Coronary Heart Disease Medication Product
Table 152. Tasly Pharmaceutical Recent Development
Table 153. Yiling Pharmaceutical Company Information
Table 154. Yiling Pharmaceutical Introduction and Business Overview
Table 155. Yiling Pharmaceutical Coronary Heart Disease Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Yiling Pharmaceutical Coronary Heart Disease Medication Product
Table 157. Yiling Pharmaceutical Recent Development
Table 158. China Shineway Pharmaceutical Company Information
Table 159. China Shineway Pharmaceutical Introduction and Business Overview
Table 160. China Shineway Pharmaceutical Coronary Heart Disease Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. China Shineway Pharmaceutical Coronary Heart Disease Medication Product
Table 162. China Shineway Pharmaceutical Recent Development
Table 163. Shanghai Pharmaceuticals Company Information
Table 164. Shanghai Pharmaceuticals Introduction and Business Overview
Table 165. Shanghai Pharmaceuticals Coronary Heart Disease Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Shanghai Pharmaceuticals Coronary Heart Disease Medication Product
Table 167. Shanghai Pharmaceuticals Recent Development
Table 168. Green Valley Company Information
Table 169. Green Valley Introduction and Business Overview
Table 170. Green Valley Coronary Heart Disease Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Green Valley Coronary Heart Disease Medication Product
Table 172. Green Valley Recent Development
Table 173. North China Pharmaceutical Company Information
Table 174. North China Pharmaceutical Introduction and Business Overview
Table 175. North China Pharmaceutical Coronary Heart Disease Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. North China Pharmaceutical Coronary Heart Disease Medication Product
Table 177. North China Pharmaceutical Recent Development
Table 178. PKU HealthCare Company Information
Table 179. PKU HealthCare Introduction and Business Overview
Table 180. PKU HealthCare Coronary Heart Disease Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. PKU HealthCare Coronary Heart Disease Medication Product
Table 182. PKU HealthCare Recent Development
Table 183. Zhejiang Ruibang Laboratories Company Information
Table 184. Zhejiang Ruibang Laboratories Introduction and Business Overview
Table 185. Zhejiang Ruibang Laboratories Coronary Heart Disease Medication Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 186. Zhejiang Ruibang Laboratories Coronary Heart Disease Medication Product
Table 187. Zhejiang Ruibang Laboratories Recent Development
Table 188. Key Raw Materials Lists
Table 189. Raw Materials Key Suppliers Lists
Table 190. Coronary Heart Disease Medication Market Trends
Table 191. Coronary Heart Disease Medication Market Drivers
Table 192. Coronary Heart Disease Medication Market Challenges
Table 193. Coronary Heart Disease Medication Market Restraints
Table 194. Coronary Heart Disease Medication Distributors List
Table 195. Coronary Heart Disease Medication Downstream Customers
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Coronary Heart Disease Medication Product Picture
Figure 2. Global Coronary Heart Disease Medication Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Coronary Heart Disease Medication Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Coronary Heart Disease Medication Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Nitrates
Figure 6. Global Nitrates Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Thrombolytic Drugs
Figure 8. Global Thrombolytic Drugs Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of β - receptor Blockers
Figure 10. Global β - receptor Blockers Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Calcium Channel Blockers
Figure 12. Global Calcium Channel Blockers Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Product Picture of Renin Angiotensin System Inhibitors
Figure 14. Global Renin Angiotensin System Inhibitors Sales YoY Growth (2018-2029) & (K Units)
Figure 15. Product Picture of Statins
Figure 16. Global Statins Sales YoY Growth (2018-2029) & (K Units)
Figure 17. Product Picture of Proprietary Chinese Medicines
Figure 18. Global Proprietary Chinese Medicines Sales YoY Growth (2018-2029) & (K Units)
Figure 19. Product Picture of Others
Figure 20. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 21. Global Coronary Heart Disease Medication Sales by Type (2018-2029) & (US$ Million)
Figure 22. Global Coronary Heart Disease Medication Sales Market Share by Type in 2022 & 2029
Figure 23. North America Coronary Heart Disease Medication Sales Market Share in Volume by Type in 2022
Figure 24. North America Coronary Heart Disease Medication Sales Market Share in Value by Type in 2022
Figure 25. Europe Coronary Heart Disease Medication Sales Market Share in Volume by Type in 2022
Figure 26. Europe Coronary Heart Disease Medication Sales Market Share in Value by Type in 2022
Figure 27. Asia-Pacific Coronary Heart Disease Medication Sales Market Share in Volume by Type in 2022
Figure 28. Asia-Pacific Coronary Heart Disease Medication Sales Market Share in Value by Type in 2022
Figure 29. Latin America Coronary Heart Disease Medication Sales Market Share in Volume by Type in 2022
Figure 30. Latin America Coronary Heart Disease Medication Sales Market Share in Value by Type in 2022
Figure 31. Middle East and Africa Coronary Heart Disease Medication Sales Market Share in Volume by Type in 2022
Figure 32. Middle East and Africa Coronary Heart Disease Medication Sales Market Share in Value by Type in 2022
Figure 33. The 5 and 10 Largest Manufacturers in the World: Market Share by Coronary Heart Disease Medication Sales in 2022
Figure 34. The 5 and 10 Largest Manufacturers in the World: Market Share by Coronary Heart Disease Medication Revenue in 2022
Figure 35. Coronary Heart Disease Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Product Picture of Hospital
Figure 37. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 38. Product Picture of Clinic
Figure 39. Global Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 40. Product Picture of Others
Figure 41. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 42. Global Coronary Heart Disease Medication Sales by Application (2018-2029) & (US$ Million)
Figure 43. Global Coronary Heart Disease Medication Sales Market Share by Application in 2022 & 2029
Figure 44. North America Coronary Heart Disease Medication Sales Market Share in Volume by Application in 2022
Figure 45. North America Coronary Heart Disease Medication Sales Market Share in Value by Application in 2022
Figure 46. Europe Coronary Heart Disease Medication Sales Market Share in Volume by Application in 2022
Figure 47. Europe Coronary Heart Disease Medication Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific Coronary Heart Disease Medication Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific Coronary Heart Disease Medication Sales Market Share in Value by Application in 2022
Figure 50. Latin America Coronary Heart Disease Medication Sales Market Share in Volume by Application in 2022
Figure 51. Latin America Coronary Heart Disease Medication Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa Coronary Heart Disease Medication Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. Coronary Heart Disease Medication Manufacturing Cost Structure
Figure 55. Coronary Heart Disease Medication Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed